These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38716720)

  • 1. Predictors of cardiovascular risk in familial hypercholesterolemia.
    Romero-Jiménez MJ; Mansilla-Rodríguez ME
    Curr Opin Endocrinol Diabetes Obes; 2024 May; ():. PubMed ID: 38716720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of cardiovascular risk in familial hypercholesterolemia.
    Romero-Jiménez MJ; Mansilla-Rodríguez ME; Gutiérrez-Cortizo EN
    Curr Opin Lipidol; 2023 Dec; 34(6):272-277. PubMed ID: 37769168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
    Mata P; Alonso R; Pérez de Isla L
    Curr Opin Lipidol; 2018 Dec; 29(6):445-452. PubMed ID: 30382952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
    Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
    Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia.
    Gallo A; Pérez de Isla L; Charrière S; Vimont A; Alonso R; Muñiz-Grijalvo O; Díaz-Díaz JL; Zambón D; Moulin P; Bruckert E; Mata P; Béliard S;
    JACC Cardiovasc Imaging; 2021 Dec; 14(12):2414-2424. PubMed ID: 34274263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype.
    Ramos R; Masana L; Comas-Cufí M; García-Gil M; Martí-Lluch R; Ponjoan A; Plana N; Alves-Cabratosa L; Marrugat J; Elosua R; Dégano IR; Gomez-Marcos MA; Zamora A
    Atherosclerosis; 2020 Jan; 292():42-51. PubMed ID: 31759248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting cardiovascular disease in familial hypercholesterolemia.
    Paquette M; Baass A
    Curr Opin Lipidol; 2018 Aug; 29(4):299-306. PubMed ID: 29708923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia.
    Pérez de Isla L; Ray KK; Watts GF; Santos RD; Alonso R; Muñiz-Grijalvo O; Diaz-Diaz JL; Badimon L; Catapano AL; Mata P
    Atherosclerosis; 2019 Jul; 286():40-45. PubMed ID: 31100618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society.
    Funabashi S; Kataoka Y; Hori M; Ogura M; Nakaoku Y; Nishimura K; Doi T; Nishikawa R; Tsuda K; Noguchi T; Harada-Shiba M
    JACC Asia; 2021 Sep; 1(2):245-255. PubMed ID: 36338164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
    J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
    Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
    Alonso R; Argüeso R; Álvarez-Baños P; Muñiz-Grijalvo O; Diaz-Diaz JL; Mata P
    Curr Atheroscler Rep; 2022 Jun; 24(6):427-434. PubMed ID: 35386090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
    Kataoka Y; Funabashi S; Doi T; Harada-Shiba M
    J Atheroscler Thromb; 2022 Jun; 29(6):795-807. PubMed ID: 35022364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.